(Q40809967)

English

AS03-adjuvanted H7N1 detergent-split virion vaccine is highly immunogenic in unprimed mice and induces cross-reactive antibodies to emerged H7N9 and additional H7 subtypes

scientific article published on 19 June 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

AS03-adjuvanted H7N1 detergent-split virion vaccine is highly immunogenic in unprimed mice and induces cross-reactive antibodies to emerged H7N9 and additional H7 subtypes (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Jacqueline M. Katz

8

object named as

Jacqueline M Katz

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Corey P Mallett

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Edith Beaulieu

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Marie-Hélène Joly

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Benoît Baras

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Xiuhua Lu

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Feng Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Min Z Levine

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sandra L Giannini

10

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

19 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

3784-3787

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Influenza in migratory birds and evidence of limited intercontinental virus exchange

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Surveillance of influenza A virus in migratory waterfowl in northern Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Characterization of H7 influenza A virus in wild and domestic birds in Korea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Novel avian influenza H7N3 strain outbreak, British Columbia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Avian influenza virus isolated from a woman with conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Highly pathogenic avian influenza A(H7N3) virus in poultry workers, Mexico, 2012.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Human infection with a novel avian-origin influenza A (H7N9) virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Epidemiology of human infections with avian influenza A(H7N9) virus in China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Limited airborne transmission of H7N9 influenza A virus between ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

A recombinant viruslike particle influenza A (H7N9) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Divergent H7 immunogens offer protection from H7N9 virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.053

7 January 2021

Identifiers

10.1016/J.VACCINE.2015.06.053

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40809967&oldid=1907810838"